About
Technology
Issues
FAQ
Links
Official Page
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.